Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumithra J Mandrekar

Showing results (51-60 of 157) with videos related to

Pageof 16
Sort By:
JCO Precision Oncology|March 20, 2020
Discussion of Trial Designs for Biomarker Identification and Validation Through the Use of Case StudiesFang-Shu Ou, Ming-Wen An, Amy S Ruppert, et al.
Statistics in Medicine|September 17, 2016
A Bayesian dose-finding design incorporating toxicity data from multiple treatment cyclesJun Yin, Rui Qin, Monia Ezzalfani, et al.
Contemporary Clinical Trials|April 29, 2014
Exploring the statistical and clinical impact of two interim analyses on the Phase II design with option for direct assignmentMing-Wen An, Sumithra J Mandrekar, Martin J Edelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 25, 2020
Clinical Versus Statistical Significance in Studies of Thoracic MalignanciesSuzanne E Dahlberg, Edward L Korn, Jennifer Le-Rademacher, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Multipopulation Tailoring Clinical Trials: Design, Analysis, and Inference ConsiderationsBrian A Millen, Alex Dmitrienko, Sumithra J Mandrekar, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|June 14, 2019
Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical TrialsJennifer G Le-Rademacher, Elizabeth M Storrick, Aminah Jatoi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 3, 2025
Was it Worth It? Response Data from >650 United States and International Participants in Chemoprevention TrialsDavid Zahrieh, Carrie A Strand, Paul J Limburg, et al.
Statistics in Medicine|January 22, 2013
Dose-finding designs using a novel quasi-continuous endpoint for multiple toxicitiesMonia Ezzalfani, Sarah Zohar, Rui Qin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2020
Neoadjuvant Immunotherapy for NSCLC: Current Concepts and Future ApproachesDipesh Uprety, Sumithra J Mandrekar, Dennis Wigle, et al.
Cancer Treatment Reviews|February 2, 2016
Clinical trial designs incorporating predictive biomarkersLindsay A Renfro, Himel Mallick, Ming-Wen An, et al.
Pageof 16

Showing results (51-60 of 157) with videos related to

Sort By:
Pageof 16
JCO Precision Oncology|March 20, 2020
Discussion of Trial Designs for Biomarker Identification and Validation Through the Use of Case StudiesFang-Shu Ou, Ming-Wen An, Amy S Ruppert, et al.
Statistics in Medicine|September 17, 2016
A Bayesian dose-finding design incorporating toxicity data from multiple treatment cyclesJun Yin, Rui Qin, Monia Ezzalfani, et al.
Contemporary Clinical Trials|April 29, 2014
Exploring the statistical and clinical impact of two interim analyses on the Phase II design with option for direct assignmentMing-Wen An, Sumithra J Mandrekar, Martin J Edelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 25, 2020
Clinical Versus Statistical Significance in Studies of Thoracic MalignanciesSuzanne E Dahlberg, Edward L Korn, Jennifer Le-Rademacher, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Multipopulation Tailoring Clinical Trials: Design, Analysis, and Inference ConsiderationsBrian A Millen, Alex Dmitrienko, Sumithra J Mandrekar, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|June 14, 2019
Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical TrialsJennifer G Le-Rademacher, Elizabeth M Storrick, Aminah Jatoi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 3, 2025
Was it Worth It? Response Data from >650 United States and International Participants in Chemoprevention TrialsDavid Zahrieh, Carrie A Strand, Paul J Limburg, et al.
Statistics in Medicine|January 22, 2013
Dose-finding designs using a novel quasi-continuous endpoint for multiple toxicitiesMonia Ezzalfani, Sarah Zohar, Rui Qin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2020
Neoadjuvant Immunotherapy for NSCLC: Current Concepts and Future ApproachesDipesh Uprety, Sumithra J Mandrekar, Dennis Wigle, et al.
Cancer Treatment Reviews|February 2, 2016
Clinical trial designs incorporating predictive biomarkersLindsay A Renfro, Himel Mallick, Ming-Wen An, et al.
Pageof 16